Predictors of Health-related Quality of Life and Adjustment to Prostate Cancer During Active Surveillance

Published on Jul 1, 2013in European Urology17.947
· DOI :10.1016/J.EURURO.2013.01.009
Lara Bellardita10
Estimated H-index: 10
,
Tiziana Rancati27
Estimated H-index: 27
+ 8 AuthorsRiccardo Valdagni51
Estimated H-index: 51
Sources
Abstract
Abstract Background Active surveillance (AS) is emerging as an alternative approach to limit the risk of overtreatment and impairment of quality of life (QoL) in patients with low-risk localised prostate cancer. Although most patients report high levels of QoL, some men may be distressed by the idea of living with untreated cancer. Objective To identify factors associated with poor QoL during AS. Design, setting, and participants Between September 2007 and March 2012, 103 patients participated in the Prostate Cancer Research International Active Surveillance (PRIAS) QoL study. Mental health (Symptom Checklist-90), demographic, clinical, and decisional data were assessed at entrance in AS. Health-related QoL (HRQoL) Functional Assessment of Cancer Therapy-Prostate version and Mini-Mental Adjustment to Cancer outcomes were assessed after 10 mo of AS. Outcome measurements and statistical analysis Multivariate logistic regression models were used to identify predictors of low ( Results and limitations The mean age of the study patients was 67 yr (standard deviation: ±7 yr). Lack of partner (odds ratio [OR]: 0.08; p =0.009) and impaired mental health (OR: 1.2, p =0.1) were associated with low HRQoL ( p =0.006; area under the curve [AUC]: 0.72). The maladaptive adjustment to cancer ( p =0.047; AUC: 0.60) could be predicted by recent diagnosis (OR: 3.3; p =0.072). Poor global QoL (overall p =0.02; AUC: 0.85) was predicted by impaired mental health (OR: 1.16; p =0.070) and time from diagnosis to enrolment in AS p =0.009). Influence of different physicians on the choice of AS (OR: 0.17; p =0.044), presence of a partner (OR: 0.22; p =0.065), and diagnostic biopsy with >18 core specimens (OR: 0.89; p =0.029) were predictors of better QoL. Limitations of this study were the small sample size and the lack of a control group. Conclusions Factors predicting poor QoL were lack of a partner, impaired mental health, recent diagnosis, influence of clinicians and lower number of core samples taken at diagnostic biopsy. Educational support from physicians and emotional/social support should be promoted in some cases to prevent poor QoL.
📖 Papers frequently viewed together
178 Citations
20124.81BJUI
54 Citations
20074.81BJUI
103 Citations
References33
Newest
#1Marc A. Dall'Era (UC Davis: University of California, Davis)H-Index: 24
#2Peter C. Albertsen (University of Connecticut Health Center)H-Index: 75
Last. Mark S. Soloway (UM: University of Miami)H-Index: 100
view all 10 authors...
Context: Prostate cancer (PCa) remains an increasingly common malignancy worldwide. The optimal management of clinically localized, early-stage disease remains unknown, and profound quality of life issues surround PCa interventions. Objective: To systematically summarize the current literature on the management of low-risk PCa with active surveillance (AS), with a focus on patient selection, outcomes, and future research needs. Evidence acquisition: A comprehensive search of the PubMed and Embas...
480 CitationsSource
#1Lara BellarditaH-Index: 10
#2Guendalina Graffigna (UCSC: Catholic University of the Sacred Heart)H-Index: 29
Last. Riccardo ValdagniH-Index: 51
view all 9 authors...
Active Surveillance (AS) may represent for selected patients with low risk, potentially indolent prostate cancer (PCa) a viable alternative to radical therapies, thus reducing the risk of over-treatment. Researchers and clinicians emphasized that the choice of AS may be a controversial one as patients have the chance to avoid the side effects of radical therapies but also the burden of living with an untreated PCa. The aim of our study is to focus on the decision-making process leading patients ...
12 CitationsSource
#1Jing Xia (UW: University of Washington)H-Index: 9
#2Bruce J. Trock (Johns Hopkins University)H-Index: 86
Last. Ruth Etzioni (UW: University of Washington)H-Index: 65
view all 10 authors...
Propose:Activesurveillancehasbeenendorsedforlow-riskprostatecancer,butinformationaboutlongtermoutcomesandcomparativeeffectivenessofactivesurveillanceislacking.Thepurposeofthisstudyisto project prostate cancer mortality under active surveillance followed by radical prostatectomy versus under immediate radical prostatectomy. Experimental design: A simulation model was developed to combine information on time from diagnosis to treatment under active surveillance and associated disease progression f...
50 CitationsSource
#1Hanna Vasarainen (HYKS: Helsinki University Central Hospital)H-Index: 9
#2Utku LokmanH-Index: 6
Last. Antti Rannikko (HYKS: Helsinki University Central Hospital)H-Index: 30
view all 5 authors...
54 CitationsSource
#2Ahmedin Jemal (ACS: American Cancer Society)H-Index: 139
#3Joannie Lortet-Tieulent (IARC: International Agency for Research on Cancer)H-Index: 33
Last. Freddie Bray (IARC: International Agency for Research on Cancer)H-Index: 119
view all 6 authors...
Abstract Context Wide variation exists internationally for prostate cancer (PCa) rates due to differences in detection practices, treatment, and lifestyle and genetic factors. Objective We present contemporary variations in PCa incidence and mortality patterns across five continents using the most recent data from the International Agency for Research on Cancer. Evidence acquisition PCa incidence and mortality estimates for 2008 from GLOBOCAN are presented. We also examine recent trends in PCa i...
1,056 CitationsSource
#1Roderick C.N. van den Bergh (EUR: Erasmus University Rotterdam)H-Index: 37
#2Ida J. KorfageH-Index: 36
Last. Chris H. BangmaH-Index: 78
view all 3 authors...
Purpose of reviewActive surveillance is emerging as a serious alternative to radical therapy for low-risk prostate cancer. In a situation in which the difference in effects on disease morbidity and mortality of different treatment options for these malignancies is likely to be small, the quality of
56 CitationsSource
#1Laurence Klotz (U of T: University of Toronto)H-Index: 85
With the advent of increasingly sensitive and widely used diagnostic testing, cancer overdiagnosis in particular has emerged as a problem in multiple organ sites. This has the greatest ramifications in the case of prostate cancer because of the very high incidence of latent prostate cancer in aging men, the availability of the prostate-specific antigen (PSA) test, and the long-term effects of definitive therapy. The condition of most men with favorable-risk prostate cancer is far removed from th...
29 CitationsSource
#1Gillian C. Barnett (University of Cambridge)H-Index: 27
#2Catharine M L West (MAHSC: Manchester Academic Health Science Centre)H-Index: 77
Last. Søren M. Bentzen (UW: University of Wisconsin-Madison)H-Index: 102
view all 12 authors...
Purpose The search for clinical and biologic biomarkers associated with late radiotherapy toxicity is hindered by the use of multiple and different endpoints from a variety of scoring systems, hampering comparisons across studies and pooling of data. We propose a novel metric, the Standardized Total Average Toxicity (STAT) score, to try to overcome these difficulties. Methods and Materials STAT scores were derived for 1010 patients from the Cambridge breast intensity-modulated radiotherapy trial...
49 CitationsSource
#1Lara BellarditaH-Index: 10
#2Tiziana RancatiH-Index: 27
Last. Riccardo ValdagniH-Index: 51
view all 10 authors...
2 CitationsSource
#1Andrew J. Vickers (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 125
#2Monique J. Roobol (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 29
Last. Hans LiljaH-Index: 108
view all 3 authors...
A sophisticated reading of the randomized trial evidence suggests that, although screening for prostate cancer with prostate-specific antigen (PSA) can reduce cancer-specific mortality, it does so at considerable cost in terms of the number of men who need to be screened, biopsied, and treated to prevent one death. The challenge is to design screening programs that maximize benefits (reducing prostate cancer mortality) and minimize costs (overtreatment). Recent research has suggested that this c...
41 CitationsSource
Cited By78
Newest
#1Elizabeth Akin-Odanye (University College Hospital, Ibadan)H-Index: 1
#2Chidiebere OgoH-Index: 3
Last. Folakemi T. Odedina (UF: University of Florida)H-Index: 19
view all 6 authors...
Cancer of the prostate (CaP) is a public health problem that affects the male genitourinary system causing a significant threat to men’s quality of life (QoL). Experiencing financial constraints and poor illness perception may further compromise the QoL of men with CaP. Aim: To examine the relationship between financial toxicity and illness perception with quality of life in men with CaP. The descriptive cross-sectional study used simple random sampling technique to recruit 173 men with CaP from...
Source
#1Utku Lokman (QA: Queen Alexandra Hospital)
#2Hanna Vasarainen (UH: University of Helsinki)H-Index: 9
Last. Antti Rannikko (UH: University of Helsinki)H-Index: 30
view all 7 authors...
BACKGROUND Living with an untreated cancer may alter quality of life (QoL) in the long term. OBJECTIVE To prospectively study long-term changes in general, mental, and physical QoL in a contemporary active surveillance (AS) patient cohort with low-risk prostate cancer (PCa). DESIGN, SETTING, AND PARTICIPANTS The study population consisted of patients enrolled in the PRIAS trial in Helsinki University Hospital (n = 348). The RAND-36 questionnaire was used to assess general QoL at the start of AS ...
Source
#1D. FiorellaH-Index: 2
#2J.L. MarencoH-Index: 2
Last. José Rubio-BrionesH-Index: 15
view all 9 authors...
Resumen Introduccion y objetivos Un porcentaje no despreciable de pacientes incluidos en programas de vigilancia activa (VA) para el cancer de prostata (CaP) de bajo y muy bajo riesgo son reclasificados en la biopsia confirmatoria o desarrollan progresion de la enfermedad durante el seguimiento. Nuestro objetivo es evaluar el papel del PCA3 y el SelectMDx, de manera individual y combinada, para predecir la progresion patologica (PP) en un programa habitual de VA. Materiales y metodos Estudio pro...
1 CitationsSource
#1D. FiorellaH-Index: 2
#2J.L. MarencoH-Index: 2
Last. José Rubio-BrionesH-Index: 15
view all 9 authors...
Abstract null null Introduction & objectives null A not negligible percentage of patients included in active surveillance (AS) for low and very low risk prostate cancer (PCa) are reclassified in the confirmatory biopsy or have disease progression during follow-up. Our aim is to evaluate the role of PCA3 and SelectMDx, in an individual and combined way, in the prediction of pathological progression (PP) in a standard AS program. null null null Materials & methods null Prospective and observationa...
1 CitationsSource
#1Jae Hoon Moon (Seoul National University Bundang Hospital)H-Index: 24
#2Chang Hwan RyuH-Index: 11
Last. Young Joo Park (Seoul National University Hospital)H-Index: 58
view all 23 authors...
Context The long-term quality of life (QoL) in patients with low-risk papillary thyroid microcarcinoma (PTMC) underwent active surveillance (AS) and immediate surgery is unclear. Objective The aim of this study was to investigate the effect of initial treatment choice on 2-year QoL in patients with low-risk PTMC. Design, setting, and participants We analyzed 2,652 QoL surveys from 1,055 subjects enrolled in ongoing multicenter prospective cohort study on active surveillance of PTMC, in which the...
Source
#1Paola DordoniH-Index: 2
#1Paola DordoniH-Index: 6
Last. Lara BellarditaH-Index: 10
view all 11 authors...
OBJECTIVE: To investigate whether prostate cancer (PCa) patients' coping strategies (i.e., fighting spirit, anxious preoccupation, fatalism, helplessness/hopelessness, and avoidance) significantly change during the first 3-year follow-up period of active surveillance (AS). MATERIALS AND METHODS: Altogether, 104 patients on AS completed the Mini-Mental Adjustment to Cancer (Mini-MAC) at baseline (T0), at 10 and 12 months after diagnostic biopsy (T1 and T2, respectively) and then at 24- (T3) and 3...
3 CitationsSource
Resumen Introduccion y objetivos Dentro del cambio de paradigma de la ultima decada en el manejo del cancer de prostata (CaP), quizas el hecho mas relevante haya sido la irrupcion de la vigilancia activa (VA) como estrategia obligada en el de bajo riesgo. Realizamos una revision critica de las mejoras clinicas, anatomopatologicas y radiologicas que permiten optimizar la VA en 2021. Material y metodos Revision critica narrativa de la literatura en los temas de mejora y en los aspectos controverti...
Source
Resumen Introduccion y objetivos Dentro del cambio de paradigma de la ultima decada en el manejo del cancer de prostata (CaP), quizas el hecho mas relevante haya sido la irrupcion de la vigilancia activa (VA) como estrategia obligada en el de bajo riesgo. Realizamos una revision critica de las mejoras clinicas, anatomopatologicas y radiologicas que permiten optimizar la VA en 2021. Material y metodos Revision critica narrativa de la literatura en los temas de mejora y en los aspectos controverti...
Source
#1Sigrid Brisson Nielsen (University of Copenhagen Faculty of Health Sciences)
#2Olivia Spalletta (Brandeis University)
Last. John Brodersen (University of Copenhagen Faculty of Health Sciences)H-Index: 27
view all 4 authors...
Prostate cancer is a frequently diagnosed cancer and made up 6% of male cancer deaths globally in 2008. Its incidence varies more than 25-fold worldwide, which is primarily attributed to the implem...
1 CitationsSource
Background The psychological burden possibly deriving from not immediately undergoing radical treatment for prostate cancer (PCa) could be a potential disadvantage of active surveillance (AS), especially in the eve of some relevant clinical exams [i.e., re-biopsy, prostate-specific antigen (PSA) test, and medical examination]. Even if it is known from the literature that the majority of PCa men in AS do not report heightened anxiety, there is a minority of patients who show clinically significan...
Source